Literature DB >> 25839870

International survey on D-dimer test reporting: a call for standardization.

Giuseppe Lippi1, Armando Tripodi2, Ana-Maria Simundic3, Emmanuel J Favaloro4.   

Abstract

D-dimer is the biochemical gold standard for diagnosing a variety of thrombotic disorders, but result reporting is heterogeneous in clinical laboratories. A specific five-item questionnaire was developed to gain a clear picture of the current standardization of D-dimer test results. The questionnaire was opened online (December 24, 2014-February 10, 2015) on the platform "Google Drive (Google Inc., Mountain View; CA)," and widely disseminated worldwide by newsletters and alerts. A total of 409 responses were obtained during the period of data capture, the largest of which were from Italy (136; 33%), Australia (55; 22%), Croatia (29; 7%), Serbia (26; 6%), and the United States (21; 5%). Most respondents belonged to laboratories in general hospitals (208; 51%), followed by laboratories in university hospitals (104; 26%), and the private sector (94; 23%). The majority of respondents (i.e., 246; 60%) indicated the use of fibrinogen equivalent unit for expressing D-dimer results, with significant heterogeneities across countries and health care settings. The highest prevalence of laboratories indicated they were using "ng/mL" (139; 34%), followed by "mg/L" (136; 33%), and "µg/L" (73; 18%), with significant heterogeneity across countries but not among different health care settings. Expectedly, the vast majority of laboratories (379; 93%) declared to be using a fixed cutoff rather than an age-adjusted threshold, with no significant heterogeneity across countries and health care settings. The results of this survey attest that at least 28 different combinations of measurement units are currently used to report D-dimer results worldwide, and this evidence underscores the urgent need for more effective international joined efforts aimed to promote a worldwide standardization of D-dimer results reporting. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25839870     DOI: 10.1055/s-0035-1549092

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  7 in total

1.  Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis.

Authors:  Pablo Demelo-Rodriguez; Ana Isabel Farfán-Sedano; José María Pedrajas; Pilar Llamas; Patricia Sigüenza; María Jesús Jaras; Manuel Quintana-Diaz; Carmen Fernández-Capitán; Behnood Bikdeli; David Jiménez; Manuel Monreal
Journal:  J Thromb Haemost       Date:  2021-06-20       Impact factor: 16.036

2.  Policies and practices in haemostasis testing among laboratories in Croatia: a survey on behalf of a Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.

Authors:  Ana Bronić; Desiree Coen Herak; Sandra Margetić; Marija Milić
Journal:  Biochem Med (Zagreb)       Date:  2017-02-15       Impact factor: 2.313

3.  Verification of automated latex-enhanced particle immunoturbidimetric D-Dimer assays on different analytical platforms and comparability of test results.

Authors:  Ivana Lapić; Désirée Coen Herak; Snježana Prpić; Andrea Prce; Vanja Raščanec; Renata Zadro; Dunja Rogić
Journal:  Biochem Med (Zagreb)       Date:  2020-10-15       Impact factor: 2.313

4.  D-dimer measurement in COVID-19: Silver bullet or clinical distraction?

Authors:  Giuseppe Lippi; Emmanuel J Favaloro
Journal:  Thromb Res       Date:  2020-10-12       Impact factor: 3.944

5.  Standardization of D-dimer reporting in the COVID-19 era.

Authors:  Litao Zhang; Zhenlu Zhang
Journal:  Res Pract Thromb Haemost       Date:  2022-09-20

6.  The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on fibrinolysis.

Authors:  Jecko Thachil; Colin Longstaff; Emmanuel J Favaloro; Giuseppe Lippi; Tetsumei Urano; Paul Y Kim
Journal:  J Thromb Haemost       Date:  2020-09       Impact factor: 16.036

7.  D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: a meta-analysis.

Authors:  Daniel Martin Simadibrata; Anna Mira Lubis
Journal:  Epidemiol Infect       Date:  2020-09-07       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.